CollPlant Biotechnologies Ltd.
Stock Forecast, Prediction & Price Target
CollPlant Biotechnologies Ltd. (CLGN) stock Price Target by analysts
$11
Potential upside: 347.15%
CollPlant Biotechnologies Ltd. price prediction
What is CollPlant Biotechnologies Ltd. stock analysts` prediction?
CollPlant Biotechnologies Ltd. stock forecast: Based on 1 Wall Street analysts` predicted price targets for CollPlant Biotechnologies Ltd. in the last 3 months, the avarage price target is $11, with a high forecast of $NaN. The average price target represents a 347.15% change from the last price of $2.46.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
CollPlant Biotechnologies Ltd. stock Price Target by analysts
Full breakdown of analysts given CollPlant Biotechnologies Ltd. price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Swayampakula Ramakanth H.C. Wainwright | 0% 0/1 | 10 months ago | $11 347.15% upside | $4.34 | StreetInsider | Previous targets (0) |
Jason Kolbert EF Hutton | 0% 0/1 | about 1 year ago | $14 469.10% upside | $4.65 | StreetInsider | Previous targets (0) |
CollPlant Biotechnologies Ltd. Financial Estimates
CollPlant Biotechnologies Ltd. Revenue Estimates
CollPlant Biotechnologies Ltd. EBITDA Estimates
CollPlant Biotechnologies Ltd. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $15.64M N/A | $299K -98.08% | $10.95M 3565.21% | Avg: $14.51M Low: $14.51M High: $14.51M avg. 32.43% | Avg: $21.70M Low: $21.70M High: $21.70M avg. 49.58% | Avg: $29.96M Low: $29.96M High: $29.96M avg. 38.03% | Avg: $29.69M Low: $29.69M High: $29.69M avg. -0.90% |
Net Income
% change YoY
| $409K N/A | $-16.75M -4196.08% | $-7.01M 58.10% | Avg: $-6.34M Low: $-6.26M High: $-6.26M avg. 9.65% | Avg: $-459.50K Low: $-455.56K High: $-455.56K avg. 92.75% | Avg: $5.92M Low: $5.92M High: $5.92M avg. 1388.84% | Avg: $6.03M Low: $6.03M High: $6.03M avg. 1.92% |
EBITDA
% change YoY
| $848K N/A | $-16.02M -1989.26% | $-6.41M 59.99% | Avg: $-9.66M Low: $-9.66M High: $-9.66M avg. -50.74% | Avg: $-14.45M Low: $-14.45M High: $-14.45M avg. -49.58% | Avg: $-19.95M Low: $-19.95M High: $-19.95M avg. -38.03% | Avg: $-19.77M Low: $-19.77M High: $-19.77M avg. 0.90% |
EPS
% change YoY
| $0.04 N/A | -$1.52 -3807.31% | -$0.62 59.21% | Avg: -$0.55 Low: -$0.55 High: -$0.55 avg. 11.29% | Avg: -$0.04 Low: -$0.04 High: -$0.04 avg. 92.72% | Avg: $0.52 Low: $0.52 High: $0.52 avg. 1400.00% | Avg: $0.53 Low: $0.53 High: $0.53 avg. 1.92% |
Operating Expenses
% change YoY
| $13.57M N/A | $16.99M 25.23% | $16.48M -3.03% | Avg: $74.58M Low: $74.58M High: $74.58M avg. 352.56% | Avg: $111.56M Low: $111.56M High: $111.56M avg. 49.58% | Avg: $153.99M Low: $153.99M High: $153.99M avg. 38.03% | Avg: $152.60M Low: $152.60M High: $152.60M avg. -0.90% |
FAQ
What is CollPlant Biotechnologies Ltd. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 373.29% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -6.26M, average is -6.34M and high is -6.26M.
What is CollPlant Biotechnologies Ltd. stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 29.78% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $14.51M, average is $14.51M and high is $14.51M.
What is CollPlant Biotechnologies Ltd. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 376.48% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.55, average is -$0.55 and high is $-0.55.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering CollPlant Biotechnologies Ltd. stock. The most successful analyst is Swayampakula Ramakanth.